Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Multi-omics revealed GOT1/ALDH3A1 pathway attenuated head and neck squamous cell carcinoma and increased cisplatin sensitivity through ROS induced by mitochondrial dysfunction. | Redox Rep | 2025 | 41327788 | PubTator, text mining | PubMed |
| A metabolic-radioimmune signature predicts therapy response and immune reprogramming in non-small cell lung cancer. | Front Oncol | 2025 | 41306526 | PubTator, text mining | PubMed |
| Genotoxic formaldehyde and lipid aldehydes are sources of DNA damage in keratinocytes. | bioRxiv | 2025 | 41292832 | PubTator, text mining | PubMed |
| Establishment and validation of a prognostic risk model based on ADME-related genes in breast cancer. | Front Oncol | 2025 | 41278297 | PubTator, text mining | PubMed |
| Structure-enhanced graph meta learning for few-shot gene regulatory network inference. | Genome Biol | 2025 | 41267133 | PubTator, text mining | PubMed |
| Natural Compound Melatonin Suppresses Breast Cancer Development by Regulating Circadian Rhythm. | Nutrients | 2025 | 41228459 | PubTator, text mining | PubMed |
| Regulation of corneal stromal cell behavior by modulating curvature using a hydraulically-controlled organ chip array. | Nat Commun | 2025 | 41224754 | PubTator, text mining | PubMed |
| Integrated Approach of Machine Learning and High-Throughput Screening to Identify Chemical Probe Candidates Targeting Aldehyde Dehydrogenases. | ACS Pharmacol Transl Sci | 2025 | 41098570 | PubTator, text mining | PubMed |
| Triclabendazole inhibits PKM2 nuclear localization and glycolysis by enhancing HDAC6-mediated deacetylation in lung cancer. | J Transl Med | 2025 | 40993625 | PubTator, text mining | PubMed |
| Anticancer Activity of Ethanolic Extract of Tabernaemontana catharinensis in Breast Cancer Lines MCF-7 and MDA-MB-231. | Int J Mol Sci | 2025 | 40869430 | PubTator, text mining | PubMed |
| The Role of the ALDH Family in Predicting Prognosis and Therapy Response in Pancreatic Cancer. | Biomedicines | 2025 | 40868269 | PubTator, text mining | PubMed |
| Lysyl oxidase as a potential biomarker of lung recurrence after hepatectomy in hepatocellular carcinoma. | Sci Rep | 2025 | 40858710 | PubTator, text mining | PubMed |
| Integrative analysis of KEAP1/NFE2L2 alterations across 3600+ tumors reveals an NRF2 expression signature as a prognostic biomarker in cancer. | NPJ Precis Oncol | 2025 | 40825842 | PubTator, text mining | PubMed |
| Sad from Proteobacteria is a Structurally Distinct ALDH3 Enzyme Specialized for the Oxidation of Steroidal Aldehydes. | Biochemistry | 2025 | 40825534 | PubTator, text mining | PubMed |
| Construction and characteristics of an adjustable biomechanical in vitro corneal stromal model simulating keratoconus pathological features. | Mater Today Bio | 2025 | 40761516 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of H1-antihistamines in endometriosis-A gene regulation-based perspective. | Front Med (Lausanne) | 2025 | 40747097 | PubTator, text mining | PubMed |
| 3D Differentiation of Bone-Marrow Derived Mesenchymal Stromal Cells into the Keratocyte Lineage for Corneal Bioprinting. | Adv Healthc Mater | 2025 | 40734361 | PubTator, text mining | PubMed |
| Identification of Glycolysis-Related Genes in MAFLD and Their Immune Infiltration Implications: A Multi-Omics Analysis with Experimental Validation. | Biomedicines | 2025 | 40722708 | PubTator, text mining | PubMed |
| Peptide Drug: Design and Clinical Applications. | MedComm (2020) | 2025 | 40717901 | PubTator, text mining | PubMed |
| Chronic stress: a fourth etiology in tumorigenesis? | Mol Cancer | 2025 | 40676620 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=3